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Intravital imagingMultiphoton laser scanning microscopy has proven profound value for ex vivo 3D histology and in vivo
imaging of motionless tissue. The development of triggering systems and fast imaging methods, com-
bined with advanced preparation procedures solved the challenging task of intravital imaging of the fast
pulsating heart and major arteries in animals and further increased the popularity of intravital multipho-
ton imaging in cardiovascular research.
This review article will highlight the potential of multiphoton microscopy for the visualization and
characterization of dynamical and structural processes involved in cardiac and vascular diseases, both
in an ex vivo and an intravital animal setting. Examples will be given how multiphoton microscopy
can be applied to imaging of atherosclerotic plaque development and progression at subcellular level
as well as to intravital imaging of inflammatory processes in the heart. In addition to highlighting the
potential of multiphoton microscopy in preclinical cardiovascular research, we will discuss how this tool
and its applications may be clinically translated to support disease diagnosis and therapy in patients.
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Although death rates from cardiovascular diseases (CVD) have
been declining in recent years, they still remain one of the leading
causes of morbidity and mortality in Western societies [1]. A sig-
nificant part of life-threatening cardiovascular events (e.g.,
myocardial infarction and stroke) is triggered by atherosclerosis
of major arteries, characterized by chronic inflammation of the
blood vessel wall with resultant accumulation of modified lipopro-
teins, macrophages, and T-cells. Ultimately, atherosclerosis leads
to remodeling of the blood vessel wall due to formation of plaques.
On rupture, these lesions cause thrombosis and embolization with
consequent blockage of blood flow [2,3]. While atherosclerosis is
the most prominent cause, cardiovascular events can also be
caused by cardiac malfunctioning on a genetic (e.g., specific types
of arrhythmia’s), inflammatory (e.g., arrhythmia’s, myocarditis,
fibrosis), atherosclerotic (e.g., heart failure), or metabolic (such as
diabetes) background.
A range of non-invasive animal and clinical imaging technolo-
gies, such as magnetic resonance imaging (MRI), computed tomog-
raphy (CT), nuclear imaging (PET, SPECT), and ultrasound (US),
provide detailed anatomical and functional information on the car-
diovascular system at micro- to millimeter scale. Additionally, sev-
eral mesoscopic semi-invasive optical imaging techniques, such as
optical coherence tomography (OCT) [4], and photoacoustic
tomography (PAT) [5,6], are being used for imaging in animal
and human atherosclerosis. The application of these techniques is
well-reviewed [7,8], including their limitations regarding sensitiv-
ity, resolution, and penetration depth (Fig. 1).ig. 1. Scales of optical imaging modalities. Resolution decreases from right to left, while
anning microscopy is an intermediate imaging modality in terms of resolution, FOV, aUnfortunately, all these modalities lack spatial resolution to
yield information at (sub)cellular level [9], while such information
is crucial to improve the understanding of diseases like atherogen-
esis or cardiac arrhythmia. Such in-depth understanding, in turn, is
essential for the development of tailor-made prevention, detection,
and intervention strategies. Optical microscopy techniques (see
Fig. 1) offer the required spatial resolution and therefore allow
not only the detailed assessment of tissue morphology, but also
insights into tissue composition and cellular marker expression
at molecular level. However, high resolution comes at the price
of limited penetration depth in tissue, with invasiveness as a con-
sequence. Traditional confocal microscopy and the upcoming
super-resolution nanoscopy (STED, PALM, STORM, GSDIM, SIM)
[10] in general focus on the imaging of cellular and subcellular pro-
cesses in either cell cultures, fixed cells, or thin tissue samples
(such as histological slices). As such they have provided scientists
with a wealth of information on cellular pathways and distribution
of proteins. Also photoacoustic microscopy (PAM) [11], and optical
coherence microscopy (OCM) [12], although limited in resolution,
have found specific fields of application in cardiovascular research,
such as determination of oxygenation of blood in micro-vessels. In
this reviewwe will elaborate on multiphoton laser scanning micro-
scopy (MPLSM), a technique that due to its combination of high
resolution and high penetration depth has found broad application
in ex vivo and in vivo imaging in cardiovascular disease in both
basic and translational research.
MPLSM is used to assess cardiovascular diseases ex vivo and
in vivo in animals, while in human tissue currently only ex vivo
applications are feasible [13–17]. MPLSM overcomes many of thefield of view, tissue penetration and in vivo applicability increases. Non-linear laser
nd penetration and therefore serves as bridging modality.
Z. Wu et al. /Methods 130 (2017) 79–89 81limitations of conventional single-photon imaging modalities (con-
focal and widefield fluorescence microscopy), such as image blur-
riness due to out-of-focus fluorescence, penetration depth of less
than 50 lm, photo-toxicity, photo-activation, and photobleaching
[18,19]. These are essential advantages in the investigation of the
mostly long-term and dynamic cardiovascular disease processes
taking place in thick and scattering tissues. Its combination of high
spatial resolution in 3 dimensions (300  300  500 nm) with pen-
etration depth up to 1 mm (the exact value depending on tissue
type) has frequently been used to study intact tissue and provide
information thereof at (sub)cellular level [20], such as atheroscle-
rotic plaques [21], blood vessels [18] and hearts [22]. It allows
the simultaneous acquisition of functional, structural, and molecu-
lar information from intact contracting/dilating vessels, blood flow,
and beating hearts, offering the opportunity to study cellular pro-
cesses, such as leukocytes behavior, in their physiological environ-
ment [23], avoiding the artifacts arising during the various steps of
tissue processing required for classical histology and immunohis-
tochemistry [24] and providing true 3D tissue architecture. MPLSM
therefore provides an important link between basic research and
clinical cardiovascular imaging, since it can extend in vitro (cellu-
lar) assays and conventional microscopy to mechanistic in vivo ani-
mal studies, while on it also can be used for the evaluation of
clinical drugs and contrast agents through coupling of a fluorescent
dye.
This review will describe the principles of MPLSM and related
experimental preparation- and triggering-techniques, especially
focusing on imaging of arterial and myocardial inflammation in
animals and humans. It will address both the advantages and lim-
itations of its use in cardiovascular research on ex vivo tissue and
in vivo, and highlights how its application can support both basic
research and, in future, clinical translation.
2. Principles of MPLSM
2.1. Two-photon laser scanning microscopy (TPLSM)
Linear or single-photon fluorophore excitation, as applied in
wide-field and confocal microscopes, is achieved by a laser or
LED that emits photons in the visible wavelength region (400–
750 nm). Fluorescence then arises from fluorophores falling backFig. 2. Principle of two-photon excitation. A) The excitation volume of TPLSM is confine
contribution. B) Fluorescence represented in a simplified Jablonski diagram. When a fluo
excitation, within 1018 s, two-photon excitation is elicited and fluorescent light will befrom their excited state to their ground state (Fig. 2B). In contrast,
two-photon excitation requires the fluorophore to absorb within
approximately 1018 s two near-infrared (NIR) photons, each with
half the energy necessary for single-photon excitation [25]. As the
probability of such an excitation event is extremely low, a high and
spatially confined photon density is required. Such densities can
only be provided in the focal spot of a powerful femtosecond-
pulsed laser, incident on the sample through a high numerical
aperture lens (Fig. 2A). Consequently, fluorescent photons always
originate from the focal spot and all fluorescent photons can be
used for detection, independent of their scattering history. Pin-
holes for removal of out-of-focus fluorescence, essential in confocal
microscopy, are not needed.
Although the spatial resolution of confocal microscopy super-
sedes that of TPLSM at shallow depths [26] (since the wavelength
of excitation for TPLSM is significantly longer), due to reduced scat-
tering of the NIR excitation light, TPLSM penetrates deeper into
biological tissues without significant loss of resolution. In contrast,
in confocal microscopy the pinholes rapidly become less effective
with depth due to scattering, and therefore resolution deteriorates
rapidly. Although high photon density is needed for two-photon
excitation, this high density is only maintained for 80–100 fem-
toseconds. Consequently, the average energy output of the NIR
laser is much lower than that of continuous lasers, which reduces
photo-damage, photo-toxicity, and photo-bleaching. Photo-
toxicity is further reduced by the use of NIR light and by confine-
ment of absorption to the focal spot, enabling long-term in vivo
time-lapse measurements [27]. Finally, due to broadening of
two-photon absorption spectra relative to their single-photon
counterparts, TPLSM allows the simultaneous excitation of multi-
ple dyes with the same near-infrared excitation wavelength, yield-
ing faster multi-color imaging.
Conventional brightfield and fluorescence intravital micro-
scopes often use CCD cameras for image acquisition, while confocal
microscopy and TPLSM are based on point-to-point scanning of the
field of view. As a result, the imaging rate in the traditional type of
laser scanning microscopes is rather low, maximally 5 frames per
second for an image of 512 by 512 pixels, with possible motion
artifacts in in vivo imaging studies as a consequence. As with
almost all microscopic imaging modalities, the usage of high
numerical aperture objectives for achieving subcellular resolutiond within the focal plane, while single photon excitation shows strong out-of-focus
rophore absorbs two photons, each with half the energy necessary for single photon
emitted a few ns later.
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300  300 lm. Together with penetration depth up to 1 mm max-
imally, this limits the clinical application of microscopic imaging.
It is important to mention that tissue-dependent autofluores-
cence, although sometimes different than under single-photon
excitation, also occurs during two-photon excitation. Autofluores-
cence often proves helpful in navigating through different layers
of tissue, but also might cause problems due to its spectral overlap
with the fluorescence of targeted labels.
2.2. Second harmonic generation
Another multiphoton process, referred to as second harmonic
generation (SHG), is frequently used for label-free imaging of colla-
gen, elastin, and myosin fibers [28]. SHG is a scattering process in
which two photons interact simultaneously with a non-centro-
symmetric and densly-packed molecule, resulting in the genera-
tion of a single photon with exactly twice the energy, i.e. half the
wavelength. Consequently, using an incident wavelength of
800 nm creates a SHG signal at exactly 400 nm (blue) [29], like in
two-photon microscopy at the confined focal spot. Importantly,
SHG is a non-absorbing process, thus photo-toxicity and photo-
bleaching are absent. Notably, most of the SHG signal (90%) is
scattered in forward direction, yet the backscattered signal, as
mostly detected in microscopy set-ups, often is strong enough for
imaging of structures at the surface of the tissue. Backward signal
from deeper tissue layers is often absorbed or scattered. Although
beyond the scope of this review, it is important to note that the for-
ward and backward scattered signals also give different informa-
tion concerning size of the structures [30]. Biological non-centro-
symmetric structures that create SHG are collagen fibers, actin fil-
aments in skeletal muscle fibers, tubulin, and myosin filaments in
cardiomyocytes.
2.3. Third harmonic generation
Third harmonic generation (THG) is also a scattering process,
requiring, however, the simultaneous scattering of three photons
to create a single photon at one third of the incident wavelength.
As a result, an incident wavelength of 1200 nm is required for
THG imaging at 400 nm. The prerequisite for THG to arise is a sud-
den change in refractive index, as seen for transitions to certain tis-
sue types, such as neutral lipid depositions, myelin, and specific
cellular structures [31,32]. Unfortunately, standard multiphoton
microscopes have a limited excitation wavelength spectrum and
do not allow THG unless equipped with an Optical Parametric
Oscillator (OPO) or fs-pulsed laser in the 1100–1300 nm range.
Therefore, although THG in combination with TPLSM and SHG
might prove to be a powerful combination in the future, at the cur-
rent stage it has not found broad application yet within cardiovas-
cular imaging.3. Application of TPLSM microscopy in animal research
3.1. Transgenic mouse lines for optical imaging
The purchase or generation of fluorescent transgenic mouse
lines can be a convenient way to ensure fluorescence detection of
specific cell subpopulations in an ex vivo or in vivo setup, without
the need for complicated labeling protocols. Green fluorescent pro-
tein (GFP) is the most commonly used fluorescent reporter [33],
but GFP can easily be replaced by any of the fluorescent proteins
(e.g., YFP, DsRed, mCherry) available. The GFP-gen inserted into
the sequence of constitutively highly expressed proteins such asCX3CR1 induces GFP expression in all blood monocytes [34], while
the selective insertion behind the CD11 promoter generates fluo-
rescence only from leukocytes positive for CD11b and CD11c
(Table 1). Transgenic mouse lines allow tracking single leukocyte
subsets in heart and vasculature using intravital multiphoton
microscopy. Particularly interesting for cardiovascular imaging,
further cross breeding with ApoE/ animals creates the matching
background for diet-induced plaque development [35–37].
3.2. Imaging of atherosclerosis in major arteries ex vivo
The progression of atherosclerosis is a slow and steady process.
Therefore, histologic evaluation of major arteries and cardiovascu-
lar tissues at specific time points during disease development in
research animals is common routine in atherosclerosis research.
Unfortunately, the absence of environmental factors, such as blood
pressure and longitudinal tension, during slice preparation causes
the blood vessel to collapse and contract, leading to structural
and functional alterations [40,41]. Imaging of fresh tissue reduces
the probability of these artifacts and keeps the 3D structure intact.
However, it requires a modality like TPLSM, with its combination
of high sensitivity, subcellular resolution, and deep tissue penetra-
tion, to visualize and understand the dynamic processes that deter-
mine the onset and development of a dense structure like plaque.
Imaging of viable blood vessels ex vivo is frequently carried out
using perfusion chambers, in which intact isolated vessels are
mounted on glass pipettes, pressurized in buffer up to physiologi-
cal levels, and corrected for longitudinal tension [42]. This proce-
dure preserves vessel wall integrity and keeps them in a
physiological environment. Structural and functional vessel wall
characteristics can be assessed in 3D optical sections up to several
hours after isolation [42]. Specific labeling agents can be applied on
mounted arteries either by in vivo administration of labeling agent
prior to euthanization and tissue excision, or by ex vivo labeling of
mounted arteries extra- and/or intraluminally for improved label-
ing specificity. Mounting of arteries proved to be an elegant and
well-controllable method for investigating the binding and uptake
kinetics of for example leukocytes, platelets [43,44], fluorescent
US-microbubbles [45], and fluorescent MRI-nanoparticles [46,47]
under flow and shear stress conditions.
Arterial walls are composed of three layers, being tunica intima,
tunica media, and tunica adventitia (Fig. 3 & Supplementary video
1). The intima, the layer closest to the lumen, is a relatively thin
layer that consists of the basal membrane (mostly collagen IV),
covered by a single layer of endothelial cells, in turn covered by
the endothelial glycocalyx (EG) [48,49]. Reitsma et al. used TPLSM
on mounted carotids to study the relation between EG thickness
and platelet adhesion during atherogenesis. While in wild type
B6 mice, the EG thickness increases with age, no such increase
was observed for ApoE/ mice. The combination with intravital
widefield fluorescence microscopy showed that during atherogen-
esis platelet adhesion was significantly increased at exactly those
locations where EG growth was hampered [13], stressing the
athero-protective properties of the EG and the potential of EG-
reinforcement therapies for the prevention of disease progression.
The intima acts as a semi-permeable barrier controlling migra-
tion of cells and proteins into and out of the bloodstream. It has
been shown that both the endothelial layer and the EG have
antithrombotic, anti-inflammatory, and vasomodulatory functions
controlling platelet adherence and activation, and vasodilatation
[50] by the secretion of substances such as nitric oxide (NO).
Endothelial dysfunction is considered one of the key events in
the onset of atherogenesis [13] and therefore is the main target
for imaging of early stages of atherosclerosis [13,49]. Using a
copper-based fluorescent probe, NO production in carotid arteries
Fig. 3. Ex vivo imaging of explanted mouse carotid arteries. A) Flow chamber
displaying a carotid artery mounted on glass pipettes. B) single plane image taken
approx. 80 lm into the blood vessel, displaying all 3 layers of the vessel:
adv = adventitia, med = media, int = intima. Cell nuclei (SYTO71, red) and collagen
(SHG, blue) are visible. The position of the image within the lumen is indicated. (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
Table 1
List of transgenic mouse lines commonly used for monocyte tracking.
Background Transgene Labeled Cell Population Reference
C57BL/6J CD2-EFGP GFP expression under the CD2 promotor for CD2, CD3, CD8, TCR beta-chain, NK 1.1 positive cells [38]
C57BL/6J CD68-EGFP GFP expression under the human CD68 promotor for CD 11b and CD 115 positive cells [39]
C57BL/6J/ApoE/ c-fms-GFP GFP expression under the c-fms promotor predominantly in CD11a, CD11b, CD14 positive cells [36]
C57BL/6J CX3CR1-GFP All blood monocytes [34]
C57BL/6J/ApoE/ lysM-gfp GFP expression in correlation with the lysozyme M expression for all mature myelo-monocytic cells [35]
C57BL/6J/ApoE/ Itgax-YFP YFP expression under the CD11c promotor for CD11b and CD 11c positive cells [37]
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TPLSM 3D sectioning, it was possible to semi-quantitatively deter-
mine NO production in both endothelial and smooth muscle cells,
providing valuable information regarding the structural-functional
relationship of NO production in the vessel wall. Since altered NO
production as a consequence of endothelial dysfunction also
results in a number of other cardiovascular symptoms, such as
hypertension [53], this opens new avenues for future imaging of
structural-functional relationships.
Additionally, the dysfunction of both barrier and secretory func-
tions is accompanied by the luminal presence and release of
chemokines and cytokines [54], and overexpression of endothelial
cell adhesion molecules, such as intercellular adhesion molecule
(ICAM), vascular cell adhesion molecule (VCAM), junctional adhe-
sion molecule A (JAM-A) [55], platelet endothelial cell adhesion
molecule (PECAM/CD31), and selectins [56,57]. These processes
cause increased accumulation of inflammatory cells, such as mono-
cytes, neutrophils, and T-cells, as well as lipids in the vessel wall.
Both cell adhesion molecules and chemokines/cytokines can
potentially be used as molecular targets for detection of early
stages of lesion development using optical imaging techniques,
but since their concentration is expected to be in the nanomolar
range they require highly sensitive methods (e.g., antibody-
coated fluorescent beads [58]). This especially holds true for tar-
gets expressed deeper in the subendothelial space, as most mark-
ers will only penetrate these layers to a limited extent. TPLSM
has shown its potential as a high-resolution and high-sensitivity
imaging method for atherosclerosis in preclinical studies in small
animals, both ex vivo and in vivo [14,15,18,23,47] (Fig. 4A & B)
and can furthermore assess distribution and binding of new diag-
nostic probes and drug carriers at the tissue level. As demonstrated
by Wu et al. and Curaj et al. [59,60], fluorescently labeled ultra-
sound contrast agents, such as ICAM-1 targeted rhodamine-
loaded microbubbles, can be used for multimodal imaging of early
endothelial inflammation/atherosclerosis. Quantitative analysis of
probe binding efficiency, shear stress resistance, and distribution
can be performed. Thus, TPLSM can strongly support the develop-
ment of new molecular imaging probes for clinically applied non-
invasive imaging modalities such as ultrasound.3.3. Imaging major arteries in vivo
Leukocyte behavior and function is the key to developing ther-
apeutic strategies for atherosclerosis and myocardial infarction.
However, the leukocyte regulatory system is collaborative, hierar-
chical, competitive, and pervasive at the same time, making the
entire system seem maladaptive [61]. Therefore, it is crucial to
track leukocytes in large arteries under inflammatory conditions,
i.e. during adhesion to, rolling along, and internalization into the
vessel wall [14,36,62,63], but also to follow their behavior inside
the atherosclerotic lesion. Monocyte-derived macrophages play a
key role in both early and late stages of plaque growth, however,
it is still not fully understood how lipid loading by macrophages
affects their biology and promotes atherosclerosis [64]. While
monocyte recruitment and internalization can be studied in vitro
and ex vivo, the majority of observations in in vitro studies shows
significant differences to their in vivo behavior with respect to
subendothelial differentiation [65].
Most conventional (brightfield or fluorescence widefield)
intravital setups employ single channel high-speed CCD cameras,
which can detect platelets, monocytes, and macrophages, however
lack the ability to simultaneously visualize multiple fluorophores
or structural details of the vessel wall. Furthermore, due to their
limited tissue penetration, they do not allow the observation of
platelets and leukocytes through the vessel wall of major arteries.
Conclusively, intravital TPLSM imaging of transgenic mouse mod-
els utilizing fluorescent protein-tagged leukocyte sub-populations
already provided crucial insights on the dynamic mechanisms of
recruitment, adherence and transmigration and has the potential
to further close the gap between in vitro and preclinical settings.
Initial in vivo studies of the macro- and microvasculature
focused mainly on coping with motional artifacts while imaging
the vessel wall [23] and leukocyte interactions with the endothe-
lium [14,15]. The in vivo motional artifacts are mainly caused by
both the cardiac and respiratory cycle of living tissue, which results
in movement of tissue beds with a specific frequency. In case of
mice, the heart frequency is 5–8 Hz, while the respiratory cycle is
2–4 Hz (depending on applied anesthesia). Consequently, the
major arteries in the thoracic region will display rhythmic motion
with similar frequencies and imaging of these tissue beds in vivo
with rather slow classical laser scanning microscopes (with
512  512 frame rates of at best 5 Hz) strongly suffers from both
intra-frame and inter-frame artifacts. The intra-frame motional
artifacts are a result of the laser scanning properties of TPLSM,
where there is significant delay between the first scanned pixel
in the left top corner of the image matrix and the last scanned pixel
at the right bottom corner. As such, the tissue present in the 1–
3 mm thin focal plane during the single image formation changes,
causing deterioration of the image due to loss of focus (Fig. 5)
[23]. The inter-frame artifacts in an imaging sequence (either in
depth or over time) are caused by the disagreement of tissue in
focus between subsequent images. As a result, (three dimensional)
reconstructions of cellular processes or structures in vivo are
almost impossible to perform without adapting the current imag-
ing methods in order to reduce the impact of motional artifacts.
Fig. 4. Examples of intravital atherosclerosis (A-E) and heart (F) imaging. A) Imaging of major arteries after endothelial injury (dashed lines show the outline of the elastin
layers,) showing cell debris on the luminal side of the blood vessel (white arrows) and subendothelial expression of the inflammatory marker VCAM-1-AF568 (red) in
comparison to B) a healthy blood vessel with an intact endothelial layer (green), labeled using CD31-AF488. C) Both collagen and elastin can be imaged without labeling, using
autofluorescence (coded green) or SHG (coded red), repetitively. These structures can be visualized better after the addition of dyes, e.g., D) sulfo-rhodamine B (red) for elastin
(white arrow) or E) CNA35-FITC (green) for collagen in plaque-containing carotid artery. Enhanced accumulation of collagen can be observed in the plaque shoulder region.
Images were modified from Richard et al. (2007) and Megens et al. (2007), respectively. F) heart imaging of myocardial tissue showing *) neutrophils (blue box) and **)
resident macrophages (yellow box) – modified from Li et al. (2012). (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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using common embedding materials such as agarose. These
attempts have not been successful since no significant motion
suppression could be achieved. Besides sometimes rather non-
physiological procedures for physical suppression of tissue motion,
either by adapting the surgical preparation method [66] or by tem-
porary reduction of the heart rate or respiration [67], there are two
other strategies to (partially) overcome intra- and inter-frame arti-
facts. The first uses triggered acquisition by using the cardiac and
respiratory signals, a technique frequently applied in other imag-
ing modalities such as MRI [68]. The second applies faster and con-
tinuous scanning of moving tissue randomly and applying
extensive post-processing of the image series to detect comparable
tissue representations over time. The choice for one of the two
depends on the research question at hand. In general, the quality
of both methods regarding in vivo image series strongly depends
on stability of sample preparation (i.e. tissue drifts or loss of
immersion water may cause a shift of the in-focus tissue) andthe physiological stability of the animal (mainly depending on
anaesthesia, and body temperature).
As an example of the first method, Megens et al. [21] initially
utilized a trigger box originally designed for MRI on small labora-
tory animals (Rapid biomedical, Würzburg, Germany) combined
with image acquisition at a rate of 5–6 Hz. This method resulted
in stable image series of murine carotid and renal arteries over
time without large intra- and inter-image artifacts, however at
the costs of overall time resolution. In order to achieve the required
acquisition rates and the detection sensitivity, the number of pixels
had to be lowered and the scan speed increased. As a result, the
image quality suffered due to a degraded signal-to-noise ratio
and reduced resolution (Fig. 6). More recently, Chèvre et al. devel-
oped a method for vessel stabilization by carefully lifting the artery
from the surrounding tissue using a thin metal plate without sig-
nificantly altering the flow characteristics [36]. Additional motion
suppression was achieved by covering the artery with a coverslip.
The combination of physical tissue stabilization with different
Fig. 5. Motional artifacts and loss of focus in un-triggered in vivo TPLSM imaging. The blood pressure variation during systole and diastole causes vessel contraction and
relaxation, resulting in intra-frame and inter-frame (out-of-focus) artifacts in the images. Three subsequent optical sections of left carotid artery (C57Bl6 ApoE/ mouse)
obtained in vivo without application of external triggering. Frame rate was 2.3 Hz (1200 lps; line scan rate 1, image size 400 * 400 pixels). Cell nuclei (SYTO13, green) are
visible. Bars indicate 50 lm. Images are disturbed by intra-frame motional artifacts, causing the arterial wall to appear as a curved-like structure. Inter-frame artifact (out-of-
focus images) due to respiratory movement result in a different imaging depth of the blood vessel, depending on the phase in the cardiac cycle. During un-triggered in vivo
imaging, in focus images are rarely acquired. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 6. Triggered image acquisition and temporal resolution of cells shapes in a murine carotid artery. Un-triggered imaging produces movement artifacts, while imaging
under respiratory and cardiac triggering reduces artifacts and allows the tracking of single myeloid cells rolling (yellow arrow) and adhering (red box). Shown in blue is the
SHG signal from adventitial collagen fibers, cells are shown in green (GFP). B) Novel tissue stabilization methods allow the acquisition of z-stacks in vivo and 3D
reconstruction. Images modified from Chèvre et al. (2014). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
Z. Wu et al. /Methods 130 (2017) 79–89 85strategies of controlled image acquisition via triggering, enabled
the acquisition of 3D image stacks with relatively high frequency
(0.1–0.3 Hz per z-stack) for longer time periods (>30 min) and
showed the feasibility of 3D tracking of cells and their function
in atherosclerosis-prone arteries in vivo.
The second method is mostly urged by the latest generation of
commercially available TPLSM systems. In these systems, overall
sensitivity has drastically improved due to strongly improved
optics (apochromatic objectives with high numerical aperture
and low magnification) and detectors (hybrid detectors). More-
over, the continuous development of novel fluorophores with
improved quantum yield and stokes-shift contributes to improve-
ment of image quality [69]. As a consequence, the acquisition times
can be shortened, resulting in a strong reduction of the intra- and
inter-image artifacts. These set-ups allow acquisition rates of>30 Hz using resonance scanning (8000–12,000 Hz, [70]) or multi-
plication of the excitation laser beam (1–64 beams [71,72]),
enabling recording at video rate without significant negative
impact on the overall image quality, field of view, or resolution.
The resultant dataset consists of optical slices captured with a fre-
quency that by far exceeds the frequency of heart beat and respira-
tion (Fig. 6). Such datasets can be subjected to (sometimes
extensive) post-processing to detect matching tissue sections over
time. In most cases the (partially) undistorted images have a rhyth-
mic appearance (dependent on motion and acquisition frequency)
within the data set, which is beneficial for the selection process. As
a result of non-triggered imaging, a high number of recorded
images can be selected according to their respective motion and
imaging depth, producing multiple stacks of data out of one image
set. By exploiting an angular difference between the imaging focal
Fig. 7. 3D reconstruction of a multiphoton image stack. 3-dimensional thrombus composition and activity in carotid arteries in mice can be investigated using multi-photon
imaging combined with offline 3D reconstruction. Thrombus formation was induced by topical application of 5% ferric chloride. Due to the angular difference between the
vessel wall and the image plane, the imaged vessel appears as an ellipse. B) At a typical 23 angular difference, 1 lm in the x-direction creates a z-component of 0.42 lm. C)
Subset of multi photon images of a platelet thrombus, showing platelets (green) and fibrinogen (red) at various focal planes. The x-position where the vessel wall intersects
the image plane can be determined for each individual image. Scale bar 100 mm. D) Volume rendering using ImageJ software of the slices shown in C. By monitoring the x-
position in each image a z-stack can be reconstructed with known inter-slice z-distances. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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performed on a high speed acquisition dataset (Fig. 7 and Supple-
mentary video 2). Secondly, non-moving structures or cells within
the selected images may be matched using overlays, edge detec-
tion, or co-localization protocols. The matched images may then
be used for visualization of biological structures [15] or cell recruit-
ment [14,73]. Post-processing (preferably automated) of the
acquired data may be further optimized by making use of the sig-
nal recordings of the motion disturbances, e.g. electrocardiography
or respiratory signals.3.4. Imaging of ECM
In addition to the molecular and functional imaging possibilities
described above, TPLSM has become a popular imaging modality
for structural visualization of the extracellular matrix components
of vessel walls, e.g., elastin in the tunica media or collagen in the
tunica adventitia [74]. During lesion progression, the vessel wall
undergoes structural remodeling, such as increase of intima-
media thickness (IMT), alteration of EG thickness [13,49], increased
smooth muscle cell proliferation, increased collagen synthesis, and
increased vasa vasorum in the tunica adventitia [73].
The tunica adventitia of large blood vessels contains large
amounts of various types of collagen, responsible for vascular
integrity, (age-related changes in) vascular stiffness, hypertension,
and plaque stability [75,76,30–32]. Its extensive contribution to
and impact on vascular remodeling and plaque development has
been reviewed by Adiguzel et al. in 2009 [77]. Collagen has been
the focus of many cardiovascular-related studies using multipho-
ton microscopy [21,78–80] because of multiphoton tissue penetra-
tion into the deeper vessel layers, label-free collagen imaging using
SHG, and because collagen is an essential factor during cardiovas-
cular disease progression (Figs. 3B & 4C) [81].The complex mechanisms and dysfunctional balance of collagen
synthesis and degradation during atherogenesis has a major
impact on disease progression. Collagen content can spike up to
60% of total plaque proteins, therefore contributing significantly
to plaque growth and arterial narrowing in fibrous lesions. Alterna-
tively, collagen degradation in the fibrous cap renders the plaque
vulnerable and prone to rupture. It should be noted, however, that
only specific types of collagen such as collagen I, III, IV, V, and VIII,
along the subendothelial layer are actively involved in plaque
development and rupture [77,82]. Also, SHG detection is more dif-
ficult deeper in the tissue since SHG is mainly forward scattered
and as such backward (epifluorescence) detection is not efficient.
This creates the need for collagen specific dyes, as demonstrated
in a study by Megens et al. in 2007, where the collagen-marker
CNA35 [83] was characterized and established as a molecular mar-
ker for atherosclerotic plaques in ApoE/ mice [21]. Due to char-
acteristic increase of endothelial permeability and elevated
collagen content in lesion areas, CNA35 showed significantly
higher binding in lesions compared to healthy tissue (Fig. 4 E).
Other extracellular matrix (ECM)-related proteins, such as elas-
tin and endothelial fibrin [21,84,85], could serve as markers for
studying atherosclerotic cap formation and cap thinning. Elastin
can be visualized both with auto-fluorescence and exogeneous
staining (e.g. using Sulfo-rhodamine B or Eosin, Fig. 4 A, C, and
D). It has been shown by Lilledahl et al. that solely based on the
elastin/collagen ratio, atherosclerotic plaques can specifically be
identified [86,87].3.5. Imaging of the heart
Myocardial inflammation and ischemia can be considered pre-
cursors to clinical symptoms and complications which are inten-
sely investigated in vivo at macroscopic resolution levels using
Z. Wu et al. /Methods 130 (2017) 79–89 87non-invasive techniques [88]. Mechanistic studies on arrhythmia
and inflammation are often conducted in vitro on cell cultures or
ex vivo on tissue slices [89,90]. Previously, TPLSM has been
involved in some of these studies on ex vivo slabs of cardiac tissue
[88,91,92] or ex vivo Langendorff-perfused hearts [93–96]. Even
more so, intravital heart imaging with subcellular resolution has
been very limited, but has been gaining interest due to technolog-
ical advances in video rate microscopes, triggering systems, and
innovative tissue preparation methods. Yet, the heart is more
affected by severe motional artifacts than any other organ, and
as such it is still one of the most challenging organs to apply
in vivo two-photon microscopy to. In order to (partially) overcome
in vivo motional artifacts, timing of the image acquisition between
the tissue movements is a logical step. When image acquisition fre-
quency is significantly higher than motional frequency, one can
record a single image without intra-image disturbances. Addition-
ally, when motional frequency is very stable and acquisition fre-
quency is high enough, it will be possible to overcome inter-
image disturbances and as a result studying of structures and/or
processes in 3D over time becomes feasible. This was for example
demonstrated for intravital and confocal imaging of the lung [97].
By mechanically controlling the respiration, a stable respiration
motional frequency was obtained that allowed image acquisition
in between the respiration frequency without intra-image artifacts.
Only recently, first attempts have been made to visualize a
beating mouse heart in vivo at subcellular resolution. Li et al. used
a model involving heterotopic transplants and an imaging chamber
[98,22] (Fig. 4 F) to study the migration and extravasation of mono-
cytes into inflamed coronary blood vessels and cardiac tissue over
a time period of 3 h. In vivo TPLSM allowed tracking of single cells
and quantification of leukocyte migration parameters, such as roll-
ing velocities, crawling velocities, and displacement directionality
after extravasation. In vivo imaging of the heart has been further
refined by Lee et al. [99], who elegantly combined existing trigger-
ing methods with a heart-stabilizing tool that suppresses part of
the motion of the beating heart inside the pericardial cavity. The
impressive result is high resolution imaging of the intact in vivo
mouse heart over several hours, during which endothelial leuko-
cyte recruitment and tracking of monocytes in the beating heart
was achieved. Most recently, Lee & Weissleder et al. developed a
new two-photon method for intravital visualization of murine
heart at subcellular resolution, quantifying myocyte contraction,
arrhythmia, and ischemic injury [100].
These studies exemplify that in vivo heart studies are indeed
feasible and open new avenues for various research areas, such
as cardiac fibrosis, angiogenesis, valve malfunction, and arrhyth-
mia, also areas where fibrosis plays an important role and the pos-
sibility of collagen imaging comes into play [88,101–104].4. Future directions
Although the feasibility of MPLSM in in vivo applications for car-
diovascular research has been demonstrated in animals, there have
been no reports on its application in humans. Until now, clinical
multiphoton microscopic (i.e., two-photon, SHG, and Coherent
Anti-Stokes Raman) imaging has almost exclusively been used on
human skin, both ex vivo and in vivo [105–107]. Due to limited
light penetration through the skin, in vivo cardiovascular multipho-
ton imaging requires procedures either to expose the tissue of
interest to create a surgically embedded optical window or the
application of an endoscope.
As already developed and established a decade ago, the combi-
nation of (confocal) fluorescence imaging and endoscopy offers the
possibility of non- or minimal invasive imaging in humans [108].
Commercial confocal endoscopes, although with more limited res-olution than confocal microscopes, are available and have for
example been used for detection of tumors in the gastrointestinal
tract or lung [109–112]. Contradictory to the increasing usage of
single-photon confocal endoscopy studies in humans in clinical
routine, there has been only one TPLSM endoscopy study in
humans [113]. The major challenges are the efficient delivery of
femtosecond excitation light without major pulse deformation,
the wide-field collection of multiphoton fluorescence, and the
miniaturization of objective lenses endoscope. Recent technologi-
cal innovations in photonic crystal fibers [114] and imaging lenses
(fiber-coupled gradient-index – GRIN lenses) [115] have partially
overcome these limitations. Several multiphoton endoscopes have
been developed and tested in animal studies [116,117]. Recent
advances, applying the combination of super-resolution and two-
photon microscopy have further advanced this field by increasing
the resolution to subcellular level [118]. This will most likely con-
tribute to the development of clinical multiphoton endoscope pro-
totypes, potentiating clinical studies outside of the dermatological
field in the next years.
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